Mechanisms and Design Principles of Proteolysis-Targeting Chimeras and Their Emerging Applications. [PDF]
ACS Pharmacol Transl SciKnoll N, Neamati N, Üren A.
europepmc +1 more source
PROTAC-based protein degradation: a window of opportunity for melanoma therapy. [PDF]
J Biomed SciGentile G +6 more
europepmc +1 more source
Targeted protein degradation: species, diseases and efficient utilization. [PDF]
J Transl MedYue T, He J, Hou J.
europepmc +1 more source
Induced-proximity therapeutics for targeted protein and RNA degradation: An organic chemistry Perspective-A review. [PDF]
Curr Res Struct BiolRizehbandi M +4 more
europepmc +1 more source
Next-Generation Proteolysis-Targeting Chimeras in Precision Oncology: Multifunctional Designs, Emerging Modalities, and Translational Prospects in Targeted Protein Degradation. [PDF]
Drug Dev ResNafie MS +6 more
europepmc +1 more source
Recent Advances in the Development of Pro-PROTAC for Selective Protein Degradation. [PDF]
PharmaceuticsHakem F +6 more
europepmc +1 more source
PROTAC-mediated multi-target protein degradation in Alzheimer's disease: mechanistic insights, therapeutic applications, and translational challenges. [PDF]
RSC Med ChemWang B +7 more
europepmc +1 more source
Design and Synthesis of Novel Candidate CK1δ Proteolysis Targeting Chimeras (PROTACs). [PDF]
MoleculesArnold M +5 more
europepmc +1 more source
Antioxidant Natural Compounds Integrated with Targeted Protein Degradation: A Multi-Modal Strategy for Alzheimer's Disease Therapy. [PDF]
Antioxidants (Basel)Singh DD, Yadav DK, Shin D.
europepmc +1 more source
Prospects and advances of PROTAC in the treatment of hematologic malignancies. [PDF]
Exp Hematol OncolWang X, Zhang M, Mei H.
europepmc +1 more source